Screener
Eligibility screening
Evaluate Soquelitinib in Participants With Moderate to Severe AD
1 US site in CA
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
Evaluate Soquelitinib in Participants With Moderate to Severe AD
1 US site in CA
Before we begin
Your answer affects how the questions are phrased.